ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
BeyondSpring Inc

BeyondSpring Inc (BYSI)

1.615
-0.0457
(-2.75%)
Cerrado 28 Diciembre 3:00PM
1.615
0.00
(0.00%)
Fuera de horario: 5:24PM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
1.615
Postura de Compra
1.50
Postura de Venta
1.63
Volume Operado de la Acción
31,634
1.60 Rango del Día 1.7755
0.7777 Rango de 52 semanas 4.00
Capitalización de Mercado [m]
Precio Anterior
1.6607
Precio de Apertura
1.63
Última hora de negociación
Volumen financiero
US$ 51,770
Precio Promedio Ponderado
1.6365
Volumen promedio (3 m)
24,542
Acciones en circulación
39,029,163
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.99
Beneficio por acción (BPA)
-0.54
turnover
1.75M
Beneficio neto
-21.03M

Acerca de BeyondSpring Inc

BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities... BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sede
New York, New York, USA
Fundado
-
BeyondSpring Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BYSI. The last closing price for BeyondSpring was US$1.66. Over the last year, BeyondSpring shares have traded in a share price range of US$ 0.7777 to US$ 4.00.

BeyondSpring currently has 39,029,163 shares in issue. The market capitalisation of BeyondSpring is US$64.82 million. BeyondSpring has a price to earnings ratio (PE ratio) of -2.99.

BYSI Últimas noticias

BeyondSpring Presents Updated Efficacy Results from a Phase 2 IIT Study of Triple IO Combo of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on Prior Immune Checkpoint Inhibitors at the 39th SITC Annual Meeting

FLORHAM PARK, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company developing innovative...

BeyondSpring Presents Efficacy/Safety Results from a Phase 2 Study of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on First-Line Immune Checkpoint Inhibitors at ESMO Congress 2024

FLORHAM PARK, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company developing innovative...

BeyondSpring Delivers Oral Presentation at ISLAC 2024 World Conference on Lung Cancer of its Lead Anti-Cancer Asset Plinabulin Showcasing Positive Final Phase 3 Data in 2L/3L NSCLC EGFR Wild-Type with Concurrent Publication in the Lancet Respiratory Medici

- Statistically Significant and Clinically Meaningful Efficacy Data with Favorable Benefit/Risk ratio from DUBLIN-3 Phase 3 Study of Plinabulin plus Docetaxel vs. Docetaxel in EGFR Wild-Type NSCLC...

BeyondSpring Announces Oral Presentation at the 2024 World Conference on Lung Cancer and Two Poster Presentations During ESMO Congress 2024 Showcasing its Lead Anti-Cancer Asset, Plinabulin

FLORHAM PARK, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing...

SEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discover and Develop Novel Molecular Glue Degraders for Neurodegeneration and Oncology Indications

The SEED-Eisai Research Collaboration leverages Eisai’s leading expertise in neurodegeneration and cancer. SEED is entitled to receive upfront and milestone payments of up to $1.5 billion plus...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.0654.19354838711.551.751.5266481.63454771CS
4-0.2771-14.64510332431.89211.941.43326581.63701922CS
12-0.685-29.78260869572.32.53121.43245421.8471491CS
26-0.795-32.98755186722.412.61.43252822.0144577CS
520.72581.46067415730.8940.7777824512.54694296CS
156-3.285-67.04081632654.95.1750.5422355352.22897467CS
260-13.675-89.437540876415.29330.54245622013.15065122CS

BYSI - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de BeyondSpring?
El precio actual de las acciones de BeyondSpring es US$ 1.615
¿Cuántas acciones de BeyondSpring están en circulación?
BeyondSpring tiene 39,029,163 acciones en circulación
¿Cuál es la capitalización de mercado de BeyondSpring?
La capitalización de mercado de BeyondSpring es USD 64.82M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de BeyondSpring?
BeyondSpring ha negociado en un rango de US$ 0.7777 a US$ 4.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de BeyondSpring?
El ratio precio/beneficio de BeyondSpring es -2.99
¿Cuál es el ratio de efectivo a ventas de BeyondSpring?
El ratio de efectivo a ventas de BeyondSpring es 35.86
¿Cuál es la moneda de reporte de BeyondSpring?
BeyondSpring presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de BeyondSpring?
El último ingresos anual de BeyondSpring es USD 1.75M
¿Cuál es el último beneficio anual de BeyondSpring?
El último beneficio anual de BeyondSpring es USD -21.03M
¿Cuál es la dirección registrada de BeyondSpring?
La dirección registrada de BeyondSpring es 28 LIBERTY STREET, 39TH FLOOR, NEW YORK, NEW YORK, 10005
¿Cuál es la dirección del sitio web de BeyondSpring?
La dirección del sitio web de BeyondSpring es www.beyondspringpharma.com
¿En qué sector industrial opera BeyondSpring?
BeyondSpring opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
INTZIntrusion Inc
US$ 2.167
(381.56%)
189.59M
AILEiLearningEngines Inc
US$ 0.5932
(267.31%)
563.26M
HUBCWHub Cyber Security Ltd
US$ 0.035
(250.00%)
2.79M
GTIGraphjet Technology
US$ 0.967551
(185.83%)
398.95M
LITMSnow Lake Resources Ltd
US$ 1.61
(82.95%)
131.98M
NEUPNeuphoria Therapeutics Inc
US$ 4.11
(-92.30%)
940.73k
VIRXViracta Therapeutics Inc
US$ 0.16
(-32.49%)
9.47M
PRFXPainReform Ltd
US$ 3.48
(-28.98%)
949.52k
AIREreAlpha Tech Corporation
US$ 2.56
(-28.49%)
8.42M
AVGRAvinger Inc
US$ 0.9721
(-24.05%)
2.16M
AILEiLearningEngines Inc
US$ 0.5932
(267.31%)
563.26M
GTIGraphjet Technology
US$ 0.967551
(185.83%)
398.95M
RGTIRigetti Computing Inc
US$ 17.08
(10.62%)
305.79M
XTIAXTI Aerospace Inc
US$ 0.03935
(-1.63%)
268M
QSIQuantum Si Inc
US$ 3.585
(66.74%)
256.01M

BYSI Discussion

Ver más
Monksdream Monksdream 6 meses hace
BYSI 10Q expected Monday 6/24
👍️0
glenn1919 glenn1919 7 meses hace
BYSI.................................https://stockcharts.com/h-sc/ui?s=BYSI&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 8 meses hace
BYSI under $5
👍️0
glenn1919 glenn1919 10 meses hace
BYSI..........................................https://stockcharts.com/h-sc/ui?s=BYSI&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 10 meses hace
BYSI new 52 week high
👍️0
Monksdream Monksdream 10 meses hace
BYSI new 52 week high
👍️0
glenn1919 glenn1919 10 meses hace
BYSI................................https://stockcharts.com/h-sc/ui?s=BYSI&p=D&yr=0&mn=2&dy=12&id=p84071410134
👍️0
Monksdream Monksdream 10 meses hace
BYSI under $2
👍️0
TheFinalCD TheFinalCD 2 años hace
https://finviz.com/quote.ashx?t=BYSI&p=d
👍️0
makinezmoney makinezmoney 2 años hace
$BYSI: And shes back now................ $1.10

BOOOOOOOOOommmmmmmmmmmmmmmm


HELLO.............. nice to be on the win side here again



GO $BYSI
👍️0
Montanore Montanore 3 años hace
Nice green pop here today on a down day for the market.
👍️0
CarlCarlMcB CarlCarlMcB 3 años hace
News is Great!!!!!$$$$$$$$$$ 25.00 to 48.00
👍️0
CarlCarlMcB CarlCarlMcB 3 años hace
Your not kidding $
👍️0
CarlCarlMcB CarlCarlMcB 3 años hace
Wow I say Merry Christmas $$$$$$
45.00 65.00 let’s go!!!!
👍️0
JackAskSlap JackAskSlap 3 años hace
That'd be right up my alley treat them all like 000..
👍️0
CarlCarlMcB CarlCarlMcB 3 años hace
You think ? .000001
👍️0
Montanore Montanore 3 años hace
Egad, what a disaster.

But maybe worth picking up some bargain shares here...
👍️0
Longer Than Most Longer Than Most 3 años hace
BYSI lotto sub 6
👍️0
JackAskSlap JackAskSlap 3 años hace
Overreactions easiest money on the planet
👍️0
TheFinalCD TheFinalCD 3 años hace
$6^ bouncing some
👍️0
saigai saigai 3 años hace
damn sesn all over again. but i dodged this one got sluaghtered on sesn
👍️0
TheFinalCD TheFinalCD 3 años hace
$5 *FAIL* https://ih.advfn.com/stock-market/NASDAQ/beyondspring-BYSI/stock-news/86697907/beyondspring-fails-to-win-fda-approval-for-plinabu
👍️0
TheFinalCD TheFinalCD 3 años hace
https://ih.advfn.com/stock-market/NASDAQ/beyondspring-BYSI/stock-news/86697835/report-of-foreign-issuer-pursuant-to-rule-13a-16-o
👍️0
TheFinalCD TheFinalCD 3 años hace
In September, BeyondSpring tanked after the company gave investors a closer look at Dublin-3 data. In a nutshell, the treatment might not be any more effective than existing options.

Recent lung cancer data was a little disappointing, but investors may be missing the point here. Plinabulin isn't intended to fight cancer directly. It's meant to stop toxic chemotherapy from destroying white blood cells. A lack of white blood cells, or neutropenia, is a dangerous complication that frequently interrupts chemotherapy treatment.

On or before Nov. 30, 2021, the FDA is expected to issue an approval decision for BeyondSpring's lead candidate plinabulin. If given a green light to treat chemotherapy-induced neutropenia, it could become an important new treatment for lots of different cancer patients.

Message in reply to:

BeyondSpring To Present Final Phase 3 DUBLIN-3 Data With Plinabulin/Docetaxel Combination Versus Docetaxel Alone In 2nd/3rd Line Non-Small Cell Lung Cancer Patients With EGFR Wild Type At European Society for Medical Oncology 2021 Congress Sept. 16-21
👍️0
TheFinalCD TheFinalCD 3 años hace
BYSI 13.50 HALTED UP ^^ PENDING NEWS))))))))))
👍️0
alvaroc2 alvaroc2 3 años hace
I Was in at 26$, what price target do you have crudeoil? Thanks in advance
👍️0
cjstocksup cjstocksup 3 años hace
We had a great day today new highs $33.00.
BYSI
👍️0
crudeoil24 crudeoil24 3 años hace
33.00 > 52 wk. high!
👍️0
crudeoil24 crudeoil24 3 años hace
BeyondSpring To Present Final Phase 3 DUBLIN-3 Data With Plinabulin/Docetaxel Combination Versus Docetaxel Alone In 2nd/3rd Line Non-Small Cell Lung Cancer Patients With EGFR Wild Type At European Society for Medical Oncology 2021 Congress Sept. 16-21
👍️0
cjstocksup cjstocksup 3 años hace
I know I love it.
👍️0
makinezmoney makinezmoney 3 años hace
$BYSI: Now nicely over $31


This thing is gonna go muchhhhhhhhhhhhhhh higher



That NEWS relase 3wks ago was SUPER SOLID



GO BYSI
👍️0
crudeoil24 crudeoil24 3 años hace
The agreement with Jiangsu Hengrui is in the Greater China area for BeyondSpring's investigational drug candidate plinabulin. Plinabulin in combination with G-CSF is currently under review by the U.S. Food and Drug Administration and the China National Medical Products Administration to prevent chemotherapy-induced neutropenia. The territory for the agreement includes mainland China, Hong Kong, Macau and Taiwan.
👍️0
crudeoil24 crudeoil24 3 años hace
Exactly, on our way to $100.

$BYSI: Monster news....... Monster UPGRADE to $100 by Wainwright

No wonder its on a roll right now


This could be the next $SAVA big time mover



GO $BYSI
👍️0
crudeoil24 crudeoil24 3 años hace
BYSI moving on a co-development and commercialization agreement for chemotherapy-induced neutropenia treatment candidate.
BeyondSpring shares are trading higher after the company announced an exclusive commercialization and co-development agreement with Jiangsu Hengrui for Plinabulin in Greater China.
👍️0
cjstocksup cjstocksup 3 años hace
Told everyone to be patient. We hit new 52 week highs today.
BYSI
👍️0
BoilerRoom BoilerRoom 3 años hace
No Sir
👍️0
Actualfactual Actualfactual 3 años hace
Wow. Hope you held
👍️0
saigai saigai 3 años hace
for many people the news helps to lessen the fear of any need for an offerring beyond june 22...more money flow..we'll see
👍️0
Montanore Montanore 3 años hace
Bought some of this dip today--hard not to.
👍️0
Actualfactual Actualfactual 3 años hace
By the way the market looks it’s not beasting today
👍️0
BoilerRoom BoilerRoom 3 años hace
$BYSI I jumped back in today at $20.20. Have to swing trade this can’t sell tomorrow hope doesn’t pop today
👍️0
Actualfactual Actualfactual 3 años hace
I dunno about it breaking $20..
👍️0
BoilerRoom BoilerRoom 3 años hace
Load up BYSI going to the moon!
👍️0
BoilerRoom BoilerRoom 3 años hace
Averaging down Jesus!
👍️0
BoilerRoom BoilerRoom 3 años hace
$BYSI back in for a quick flip
👍️0
BoilerRoom BoilerRoom 3 años hace
Wonder if this will ever bottom out? You would think cancer treatments would run. I would jump back in but volume has dried up folks lost interest. Government should ban medical stocks from being shorted. Sad companies try help sick people and some A-hole comes along trying push company’s price down.
👍️0
BoilerRoom BoilerRoom 3 años hace
$BYSI dumped this for a loss made my money back on NSAV
👍️0
cjstocksup cjstocksup 3 años hace
All he was showing was his bet's. Means nothing really. I see many people post their puts and calls all day there.
👍️0
saigai saigai 3 años hace
not registered there ..thanks for the consideration..just wondering if it was a bullish sign or not.. i dont understand that part of the game.gl got 2k shares here started buying at 22. love the biotech ....clsd... gltu
👍️0
cjstocksup cjstocksup 3 años hace
I do not use options I buy stocks. The kids do but I never ask them I have way too much to do even with stocks, alt coins etc. Ask him what he means.
JarvisAlerts
03:00 PM
$BYSI 22.5P Exp:15-Oct-21 ?? ?? Total(Day): $119,151
#SmartMoneyFlow
charts: courtesy of finviz
👍️0

Su Consulta Reciente

Delayed Upgrade Clock